Applied Therapeutics Appoints Adam Hansard as Chief Commercial Officer

NEXT STORY
Kura Oncology Receives Fast Track Designation for Tipifarnib in T-Cell Lymphomas
PREV STORY
Global Proteomics Market Outlook, 2026 – $27+ Billion Opportunity Assessment with Profiles of Key Industry Players
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Intercept Announces New OCA Data in PBC and NASH to be Presented at EASL 2016

NEW YORK, March 30, 2016 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a clinical ...

author_avatar
NASDAQ Market News

BeyondSpring Provides Operational Update for Second Quarter of 2017

NEW YORK, Aug. 21, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI) (“BeyondSpring” or the ...

author_avatar
NASDAQ Market News

Sorrento Therapeutics Chairman/CEO update to stockholders

SAN DIEGO, March 28, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE) Dear Sorrento ...

author_avatar
NASDAQ Market News